Selected article for: "clinical trial and error rate"

Author: Qingyang Xu; Shomesh Chaudhuri; Danying Xiao; Andrew W Lo
Title: Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics during Epidemic Outbreaks
  • Document date: 2020_4_14
  • ID: 20hk99h4_3
    Snippet: For severe diseases with no curative treatments, such as pancreatic cancer, patients tend to tolerate a higher Type I error of accepting an ineffective therapy in exchange for a lower Type II error of rejecting an effective therapy as well as expedited approvals of potentially effective treatments. Based on this observation, a patient-centered Bayesian protocol was proposed (Isakov et al., 2018; Montazerhodjat et al., 2017) that incorporates pati.....
    Document: For severe diseases with no curative treatments, such as pancreatic cancer, patients tend to tolerate a higher Type I error of accepting an ineffective therapy in exchange for a lower Type II error of rejecting an effective therapy as well as expedited approvals of potentially effective treatments. Based on this observation, a patient-centered Bayesian protocol was proposed (Isakov et al., 2018; Montazerhodjat et al., 2017) that incorporates patient values into clinical trial design and identify the optimal balance between the possibilities of false positives (Type I error) and false negatives (Type II error). For more severe diseases, this protocol sets a tolerated Type I error rate much larger than the traditional 5% threshold, which leads to higher rates of approvals and expedited approval decisions.

    Search related documents:
    Co phrase search for related documents
    • approval decision and optimal balance: 1
    • Bayesian protocol and optimal balance: 1
    • clinical trial design and effective therapy: 1, 2
    • clinical trial design and false negative: 1
    • clinical trial design and false positive: 1, 2
    • clinical trial design and high rate: 1, 2, 3
    • curative treatment and effective therapy: 1, 2, 3, 4
    • curative treatment and high rate: 1, 2, 3, 4, 5, 6, 7, 8
    • curative treatment and ineffective therapy: 1
    • curative treatment and pancreatic cancer: 1, 2, 3, 4
    • curative treatment and pancreatic cancer curative treatment: 1, 2
    • effective therapy and false negative: 1
    • effective therapy and high rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • effective therapy and ineffective therapy: 1, 2, 3
    • effective therapy and optimal balance: 1
    • effective therapy and pancreatic cancer: 1
    • expedite approval and false positive: 1
    • false negative and high rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • false negative and optimal balance: 1